Full Text View
Tabular View
No Study Results Posted
Related Studies
Cognitive Protection - Dexmedetomidine and Cognitive Reserve
This study has been terminated.
( pilot study data no longer needed when main nih study was funded. )
Study NCT00455143   Information provided by Mount Sinai School of Medicine

First Received on April 2, 2007.   Last Updated on January 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Postoperative Delirium
PD
Postoperative Cognitive Dysfunction
POCD
Additional conditions recognized in this trial
Cognition Disorders
Delirium
More general conditions related to this trial
Confusion
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
Precedex (Dexmedetomidine)
Additional drug interventions recognized in this trial
Dexmedetomidine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Analgesics
Analgesics, Non-Narcotic
Central Nervous System Agents
Central Nervous System Depressants
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Jeff Silverstein. MD


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services